Skip to content

Brugada Syndrome 9 C4225340

Published: July 22, 2026Updated: August 20, 2026

A genetic heart condition causing abnormal electrical rhythms. More common in males and people of Asian descent. Risk of sudden death; treated with medication, implanted devices, or procedures.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest pain

!

Syncope

!

Ventricular arrhythmia

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Palpitations

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Implantable Cardioverter-Defibrillator (ICD)

ICD placement is the primary life-saving intervention for patients with Brugada syndrome 9 who meet risk criteria, providing continuous monitoring and automatic defibrillation for ventricular arrhythmias.

surgical
3

Lifestyle Modification Program

Comprehensive lifestyle changes including fever management, avoidance of sodium channel blocking medications, extreme temperature exposure, and alcohol moderation help reduce arrhythmia triggers.

lifestyle

Additional treatment options

Antiarrhythmic Medication

Quinidine or other appropriate antiarrhythmic agents may be prescribed to suppress abnormal electrical activity in the heart, particularly for patients with recurrent arrhythmic events or those awaiting ICD surgery.

medication

Risk Stratification and Follow-up

Regular cardiac monitoring with ECGs, event recorders, and periodic ICD interrogations help assess disease progression and treatment efficacy, guiding decisions about escalation of therapy.

monitoring

Family Screening and Education

Systematic ECG screening of first-degree relatives identifies additional affected family members. Education about symptom recognition and emergency response prepares families for cardiac events.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Brugada Syndrome 9 C4225340?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Antzelevitch C, Brugada P, Borggrefe M, et al. HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes. Heart Rhythm. 2013;10(10):e85-e108.

guideline2013
2

Wilde AA, Ackerman MJ, Sherman LK. Brugada Syndrome: Update on Diagnosis and Risk Stratification. J Am Coll Cardiol. 2018;72(22):2854-2872.

review2018
3

Probst V, Eckardt L, Maury P, et al. Long-term Outcomes After Implantable Cardioverter-Defibrillator Placement in Brugada Syndrome: Results from the Prospective multicenter BRUGADA Registry. Eur Heart J. 2019;40(35):2993-3001.

clinical_trial2019
4

Giustetto C, Cerrato N, Gribaudo E, et al. Quinidine for Brugada Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Circ Arrhythm Electrophysiol. 2021;14(8):e009789.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Brugada Syndrome 9 C4225340. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy